자궁경부암을 진단받은 폐경 후 여성에서 수술 및 동시항암화학방사선치료가 골밀도에 미치는 영향
Effect on Bone Mineral Density in Postmenopausal Invasive Cervical Cancer Patients with Radical Operation and CCRT
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: This study evaluated the effect on bone mineral density (BMD) in postmenopausal invasive cervical cancer patients treated with radical operation and concurrent chemoradiotherapy (CCRT). Methods: We analyzed the BMD of spinal bone and the femur in 48 invasive cervical cancer patients treated with CCRT after radical operation. All BMD was measured by dual-energy X-ray absorptiometry. For comparison with control women, 96 patients without gynecological disease whose age and body mass index are consistent with the case group were selected. The measurement interval was 1 year. All of the patients and control women had reached their menopause. Results: Age, height, body weight and body mass index were not significantly different between the two groups. The serum levels of calcium and phosphate were not significantly different between the patients with cervical cancer and control women before and after treatment. On the other hands, the concentrations of total alkaline phosphatase and osteocalcin of patients with invasive cervical cancer were significantly lower (P<0.05) than those of control women after treatment. BMD showed inconsistent outcomes, but there is a trend of decrease after operation and CCRT in invasive cervical cancer. Conclusions: Our study suggests that invasive cervical cancer patients treated with radical operation and CCRT have a lower BMD, resulting in an increased risk of osteoporosis.
Abstract
Objectives: This study evaluated the effect on bone mineral density (BMD) in postmenopausal invasive cervical cancer patients treated with radical operation and concurrent chemoradiotherapy (CCRT). Methods: We analyzed the BMD of spinal bone and the femur in 48 invasive cervical cancer patients treated with CCRT after radical operation. All BMD was measured by dual-energy X-ray absorptiometry. For comparison with control women, 96 patients without gynecological disease whose age and body mass index are consistent with the case group were selected. The measurement interval was 1 year. All of the patients and control women had reached their menopause. Results: Age, height, body weight and body mass index were not significantly different between the two groups. The serum levels of calcium and phosphate were not significantly different between the patients with cervical cancer and control women before and after treatment. On the other hands, the concentrations of total alkaline phosphatase and osteocalcin of patients with invasive cervical cancer were significantly lower (P<0.05) than those of control women after treatment. BMD showed inconsistent outcomes, but there is a trend of decrease after operation and CCRT in invasive cervical cancer. Conclusions: Our study suggests that invasive cervical cancer patients treated with radical operation and CCRT have a lower BMD, resulting in an increased risk of osteoporosis.
참고문헌 (17)
- Honig S., "Osteoporosis - new treatments and updates", Bull NYU Hosp Jt Dis, 69, pp.253~256 (2011)
- Kendler D., "Osteoporosis: therapies now and in the future", Climacteric, 14, pp.604~605 (2011)
- Tipples K, "Optimal Management of Cancer Treatment-Induced Bone Loss: Considerations for Elderly Patients", Drugs Aging, 28, pp.867~883 (2011)
- Hwang JH, "Bone mineral density after concurrent chemoradiation in patients with uterine cervical cancer", Menopause, 17, pp.416~420 (2010)
- Zaman K, "Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21", 07), 2011, pp.14, 1~7
- Aapro MS, "Bone health management in patients with breast cancer: Current standards and emerging strategies", Breast, 21, pp.8~19 (2012)
- Edwards BJ, "Cancer therapy associated bone loss: implications for hip fractures in mid-life women with breast cancer", Clin Cancer Res, 17, pp.560~568 (2011)
- Nock NL, "Higher bone mineral density is associated with a decreased risk of colorectal adenomas", Int J Cancer, 129, pp.956~964 (2011)
- Chow LW, "Bone metabolism and quality-of-life of postmenopausal women with invasive breast cancer receiving neoadjuvant hormonal therapy: sub-analyses from celecoxib anti-aromatase neoadjuvant (CAAN) trial", J Steroid Biochem Mol Biol, 125, pp.112~119 (2011)
- David C, "Severity of osteoporosis: what is the impact of co-morbidities?", Joint Bone Spine, 77, pp.S103~S106 (2010)
- Langley R, "Osteoporosis in patients withprostate cancer on long-term androgen deprivation therapy: an increasing but under-recognised problem", BJU Int, 106, pp.726~727 (2010)
- Grenier D, "Bone mineral density and risk of postmenopausal breast cancer", Breast Cancer Res Treat, 126, pp.679~686 (2011)
- Serpa Neto A, "A systematic review and meta-analysis of bone metabolism in prostate adenocarcinoma", BMC Urol, 10, pp.9~ (2010)
- Roschger P, "Bone Material Quality in Transiliac Bone Biopsies of Postmenopausal Osteoporotic Women After 3 Years Strontium Ranelate Treatment", J Bone Miner Res, 25, pp.891~900 (2010)
- Chen HH, "Changes in bone mineral density of lumbar spine after pelvic radiotherapy", Radiother Oncol, 62, pp.239~242 (2002)
- Oh D, "Pelvic insufficiency fracture after pelvic radiotherapy for cervical cancer: analysis of risk factors", Int J Radiat Oncol Biol Phys, 70, pp.1183~1188 (2008)
- Cho SH, "Reduced spinal bone mass in patients with uterine cervical cancer", Obstet Gynecol, 78, pp.689~692 (1991)